FDA Approves Relacorilant and Nab-Paclitaxel for Platinum-Resistant Ovarian Cancer
For years, gynecologic oncologists have faced a sobering reality when treating patients with platinum-resistant ovarian cancer: the options were few, and the results were often fleeting. … Read more